Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.770
+0.030 (1.72%)
Oct 14, 2026, 5:20 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 80.86 million as of October 14, 2026. It is the 42,887th most valuable company in the world and the 630th biggest in Sweden. Its market cap has decreased by 15.73% in one year.
Market Cap
80.86M
Enterprise Value
77.60M
Revenue
275.74K
Global Rank
Country Rank
#630 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 80.86M, a decrease of -44.00%. That is a compound annual growth rate of -10.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 80.86M | -6.73% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 135.88M |
| NextCell Pharma AB | 126.14M |
| OncoZenge AB | 100.05M |
| Biovica International AB | 88.45M |
| Active Biotech AB | 87.65M |
| Spago Nanomedical AB | 83.43M |
| Ascelia Pharma AB | 82.66M |
| Nanologica AB | 82.19M |